1. Home
  2. MXCT vs FNGR Comparison

MXCT vs FNGR Comparison

Compare MXCT & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • FNGR
  • Stock Information
  • Founded
  • MXCT 1999
  • FNGR 2016
  • Country
  • MXCT United States
  • FNGR Singapore
  • Employees
  • MXCT N/A
  • FNGR N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FNGR Computer Software: Prepackaged Software
  • Sector
  • MXCT Health Care
  • FNGR Technology
  • Exchange
  • MXCT Nasdaq
  • FNGR Nasdaq
  • Market Cap
  • MXCT 239.2M
  • FNGR 259.4M
  • IPO Year
  • MXCT 2021
  • FNGR N/A
  • Fundamental
  • Price
  • MXCT $2.20
  • FNGR $2.04
  • Analyst Decision
  • MXCT Strong Buy
  • FNGR
  • Analyst Count
  • MXCT 1
  • FNGR 0
  • Target Price
  • MXCT $9.00
  • FNGR N/A
  • AVG Volume (30 Days)
  • MXCT 874.5K
  • FNGR 333.0K
  • Earning Date
  • MXCT 08-05-2025
  • FNGR 07-07-2025
  • Dividend Yield
  • MXCT N/A
  • FNGR N/A
  • EPS Growth
  • MXCT N/A
  • FNGR N/A
  • EPS
  • MXCT N/A
  • FNGR N/A
  • Revenue
  • MXCT $37,675,000.00
  • FNGR $35,607,614.00
  • Revenue This Year
  • MXCT $8.82
  • FNGR N/A
  • Revenue Next Year
  • MXCT $21.12
  • FNGR N/A
  • P/E Ratio
  • MXCT N/A
  • FNGR N/A
  • Revenue Growth
  • MXCT N/A
  • FNGR N/A
  • 52 Week Low
  • MXCT $2.00
  • FNGR $1.03
  • 52 Week High
  • MXCT $5.20
  • FNGR $5.20
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 51.61
  • FNGR 36.92
  • Support Level
  • MXCT $2.00
  • FNGR $1.92
  • Resistance Level
  • MXCT $2.28
  • FNGR $2.30
  • Average True Range (ATR)
  • MXCT 0.12
  • FNGR 0.17
  • MACD
  • MXCT 0.02
  • FNGR -0.03
  • Stochastic Oscillator
  • MXCT 78.95
  • FNGR 22.40

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

Share on Social Networks: